Cargando…

Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer

Bladder cancer is one of the leading cancer of the urinary tract. It is often diagnosed at advanced stage of the disease. To date, no specific and effective early detection biomarkers are available. Cancer development and progression are associated with the involvement of both epithelial-mesenchymal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falzone, Luca, Candido, Saverio, Salemi, Rossella, Basile, Maria S., Scalisi, Aurora, McCubrey, James A., Torino, Francesco, Signorelli, Salvatore S., Montella, Maurizio, Libra, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341942/ https://www.ncbi.nlm.nih.gov/pubmed/27602581 http://dx.doi.org/10.18632/oncotarget.11805

Ejemplares similares

MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma
por: Falzone, Luca, et al.
Publicado: (2016)

Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer
por: Candido, Saverio, et al.
Publicado: (2014)

Cutaneous melanoma: From pathogenesis to therapy (Review)
por: Leonardi, Giulia C., et al.
Publicado: (2018)

Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity
por: Chappell, William H., et al.
Publicado: (2012)

Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment
por: Candido, Saverio, et al.
Publicado: (2022)

The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways
por: Candido, Saverio, et al.
Publicado: (2022)

MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAF(V600E) Mutation Detected in Circulating-Free DNA
por: Salemi, Rossella, et al.
Publicado: (2018)

Gut Microbiota and Cancer: From Pathogenesis to Therapy
por: Vivarelli, Silvia, et al.
Publicado: (2019)

Analysis of the B-RAF(V600E) mutation in cutaneous melanoma patients with occupational sun exposure
por: CANDIDO, SAVERIO, et al.
Publicado: (2014)

Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients
por: Salemi, Rossella, et al.
Publicado: (2022)

Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
por: Lavoro, Alessandro, et al.
Publicado: (2022)

Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer
por: Pappalardo, Francesco, et al.
Publicado: (2016)

Identification of Novel MicroRNAs and Their Diagnostic and Prognostic Significance in Oral Cancer
por: Falzone, Luca, et al.
Publicado: (2019)

Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer
por: Banna, Giuseppe L., et al.
Publicado: (2017)

Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells
por: Rapisarda, Venerando, et al.
Publicado: (2016)

Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma
por: Napoli, Salvatore, et al.
Publicado: (2020)

Emerging targeted therapies for melanoma treatment (Review)
por: RUSSO, ANGELA, et al.
Publicado: (2014)

Prognostic significance of deregulated microRNAs in uveal melanomas
por: Falzone, Luca, et al.
Publicado: (2019)

The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis
por: Lin, Katie, et al.
Publicado: (2022)

Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment
por: Vivarelli, Silvia, et al.
Publicado: (2020)

YY1 Silencing Induces 5-Fluorouracil-Resistance and BCL2L15 Downregulation in Colorectal Cancer Cells: Diagnostic and Prognostic Relevance
por: Vivarelli, Silvia, et al.
Publicado: (2021)

Concomitant elevations of MMP‐9, NGAL, proMMP‐9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease
por: Bchir, Sarra, et al.
Publicado: (2016)

Droplet Digital PCR Analysis of Liquid Biopsy Samples Unveils the Diagnostic Role of hsa-miR-133a-3p and hsa-miR-375-3p in Oral Cancer
por: Crimi, Salvatore, et al.
Publicado: (2020)

Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias
por: Bouchet, Sandrine, et al.
Publicado: (2014)

Cutaneous melanoma and the immunotherapy revolution (Review)
por: Leonardi, Giulia C., et al.
Publicado: (2020)

Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease
por: Provatopoulou, Xeni, et al.
Publicado: (2009)

In silico analysis of the solute carrier (SLC) family in cancer indicates a link among DNA methylation, metabolic adaptation, drug response, and immune reactivity
por: Lavoro, Alessandro, et al.
Publicado: (2023)

Environment and bladder cancer: molecular analysis by interaction networks
por: Polo, Andrea, et al.
Publicado: (2017)

Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in sera and urine of patients with kidney tumors
por: DI CARLO, ANGELINA
Publicado: (2013)

Novel Insights into Epigenetic Regulation of IL6 Pathway: In Silico Perspective on Inflammation and Cancer Relationship
por: Candido, Saverio, et al.
Publicado: (2021)

Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression
por: Steelman, Linda S., et al.
Publicado: (2017)

Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant
por: Salemi, Rossella, et al.
Publicado: (2023)

Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
por: Vivarelli, Silvia, et al.
Publicado: (2020)

Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2017)

Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development
por: Falzone, Luca, et al.
Publicado: (2018)

GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals
por: Abrams, Stephen L., et al.
Publicado: (2021)

Bevacizumab in the treatment of NSCLC: patient selection and perspectives
por: Russo, Alessia E, et al.
Publicado: (2017)

Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
por: Falzone, Luca, et al.
Publicado: (2018)

NF-κB inhibition is associated with OPN/MMP-9 downregulation in cutaneous melanoma
por: Guarneri, Claudio, et al.
Publicado: (2017)

Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma
por: Bevelacqua, Valentina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2cnf2q3mc3gsk7joqr804s4gh0